Tumor-associated macrophages contribute to colorectal cancer progression, yet the mechanisms governing their communication with the malignant epithelium remain poorly understood. CD300e is a myeloid receptor previously shown to promote immune suppression and tumor growth and to act cell-intrinsically in macrophages, but whether it shapes macrophage–epithelial crosstalk was unknown. Using co-cultures of murine tumor or normal colon organoids with bone marrow-derived macrophages from CD300e-sufficient or CD300e-deficient mice, we examined macrophage phenotype, uptake of particles, viable tumor cells and apoptotic tumor cells, and epithelial plasticity and barrier integrity, assessed through expression of epithelial-to-mesenchymal transition (EMT)-associated genes, dextran permeability and transepithelial electrical resistance. CD300e deficiency did not alter the direction of macrophage polarization but increased CD86 expression and the phagocytic capacity of polarized macrophages. Tumor organoids, but not normal organoids, increased Cd300e transcript levels in wild-type macrophages. In co-culture with tumor organoids, CD300e-deficient macrophages showed a more immunostimulatory profile, higher uptake of viable tumor cells and lower uptake of apoptotic tumor cells, together with lower expression of efferocytosis-associated receptors; these differences were significantly less evident with normal organoids. Tumor organoids exposed to CD300e-deficient macrophages showed lower expression of EMT-associated genes, improved barrier properties (reduced permeability and higher transepithelial resistance) and lower epithelial proliferation. Similar changes in efferocytosis-associated receptors and EMT-associated genes were observed in tumor-bearing CD300e-deficient mice. These findings indicate that CD300e is associated with a less immunostimulatory macrophage state and with epithelial plasticity and barrier dysfunction in colorectal cancer models, and support further evaluation of CD300e as a potential therapeutic target.

Macrophage CD300e modulates epithelial plasticity and barrier function in colorectal cancer models

Sofia Giacometti
Investigation
;
Sara Coletta
Membro del Collaboration Group
;
Stefania Vassallo
Methodology
;
Gaia Codolo
Writing – Original Draft Preparation
In corso di stampa

Abstract

Tumor-associated macrophages contribute to colorectal cancer progression, yet the mechanisms governing their communication with the malignant epithelium remain poorly understood. CD300e is a myeloid receptor previously shown to promote immune suppression and tumor growth and to act cell-intrinsically in macrophages, but whether it shapes macrophage–epithelial crosstalk was unknown. Using co-cultures of murine tumor or normal colon organoids with bone marrow-derived macrophages from CD300e-sufficient or CD300e-deficient mice, we examined macrophage phenotype, uptake of particles, viable tumor cells and apoptotic tumor cells, and epithelial plasticity and barrier integrity, assessed through expression of epithelial-to-mesenchymal transition (EMT)-associated genes, dextran permeability and transepithelial electrical resistance. CD300e deficiency did not alter the direction of macrophage polarization but increased CD86 expression and the phagocytic capacity of polarized macrophages. Tumor organoids, but not normal organoids, increased Cd300e transcript levels in wild-type macrophages. In co-culture with tumor organoids, CD300e-deficient macrophages showed a more immunostimulatory profile, higher uptake of viable tumor cells and lower uptake of apoptotic tumor cells, together with lower expression of efferocytosis-associated receptors; these differences were significantly less evident with normal organoids. Tumor organoids exposed to CD300e-deficient macrophages showed lower expression of EMT-associated genes, improved barrier properties (reduced permeability and higher transepithelial resistance) and lower epithelial proliferation. Similar changes in efferocytosis-associated receptors and EMT-associated genes were observed in tumor-bearing CD300e-deficient mice. These findings indicate that CD300e is associated with a less immunostimulatory macrophage state and with epithelial plasticity and barrier dysfunction in colorectal cancer models, and support further evaluation of CD300e as a potential therapeutic target.
In corso di stampa
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3621118
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact